Insightec
VerifiedDevelops and distributes the Exablate platform that provides noninvasive treatments for a variety of oncology and gynecology indications.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$1.3b (Public information from Jun 2024)
Tirat Karmel Haifa District (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | $150m Valuation: $1.3b | Series F | |
| N/A | N/A | - | |
* | N/A | $136m Valuation: $1.3b | Late VC |
* | $100m | Debt | |
* | $150m Valuation: $1.3b | Late VC | |
| Total Funding | $797m | ||
Recent News about Insightec
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.